4.00
price down icon4.76%   -0.20
after-market Dopo l'orario di chiusura: 4.02 0.02 +0.50%
loading
Precedente Chiudi:
$4.20
Aprire:
$4.2
Volume 24 ore:
4.56M
Relative Volume:
0.82
Capitalizzazione di mercato:
$1.47B
Reddito:
$4.09M
Utile/perdita netta:
$-660.15M
Rapporto P/E:
-1.7351
EPS:
-2.3053
Flusso di cassa netto:
$-117.10M
1 W Prestazione:
-7.62%
1M Prestazione:
+5.54%
6M Prestazione:
-10.71%
1 anno Prestazione:
+172.11%
Intervallo 1D:
Value
$3.945
$4.23
Intervallo di 1 settimana:
Value
$3.945
$4.35
Portata 52W:
Value
$1.29
$6.75

Ataibeckley Inc Stock (ATAI) Company Profile

Name
Nome
Ataibeckley Inc
Name
Telefono
1 929 207 2670
Name
Indirizzo
C/O ATAI LIFE SCIENCES US, INC., NEW YORK
Name
Dipendente
99
Name
Cinguettio
Name
Prossima data di guadagno
2026-05-13
Name
Ultimi documenti SEC
Name
ATAI's Discussions on Twitter

Compare ATAI vs VRTX, REGN, ARGX, ALNY, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ATAI icon
ATAI
Ataibeckley Inc
4.00 1.54B 4.09M -660.15M -117.10M -2.3053
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 109.34B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 74.35B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 50.44B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 39.78B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.02B 5.36B 287.73M 924.18M 2.5229

Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-03-27 Iniziato Deutsche Bank Buy
2026-01-20 Iniziato Guggenheim Buy
2025-10-13 Iniziato Needham Buy
2025-07-29 Iniziato Oppenheimer Outperform
2024-11-18 Reiterato H.C. Wainwright Buy
2024-04-03 Aggiornamento Maxim Group Hold → Buy
2022-11-01 Iniziato Loop Capital Buy
2021-11-30 Iniziato Maxim Group Buy
2021-11-11 Iniziato ROTH Capital Buy
2021-10-18 Iniziato H.C. Wainwright Buy
2021-09-01 Iniziato Jefferies Buy
2021-07-13 Iniziato Berenberg Buy
2021-07-13 Iniziato Canaccord Genuity Buy
2021-07-13 Iniziato Cantor Fitzgerald Buy
2021-07-13 Iniziato Citigroup Buy
2021-07-13 Iniziato Cowen Outperform
2021-07-13 Iniziato Credit Suisse Outperform
2021-07-13 Iniziato RBC Capital Mkts Sector Perform
2021-07-08 Iniziato Aegis Capital Buy
Mostra tutto

Ataibeckley Inc Borsa (ATAI) Ultime notizie

pulisher
May 05, 2026

ATAI stock soars on track for best day on Trump psychedelics push and Wall Street cheers - MSN

May 05, 2026
pulisher
May 02, 2026

Is AtaiBeckley (ATAI) Redefining Its Psychedelic Strategy With Standalone EMP-01 Anxiety Data? - simplywall.st

May 02, 2026
pulisher
May 01, 2026

10 Health Care Stocks With Whale Alerts In Today's SessionAbbVie (NYSE:ABBV), AtaiBeckley (NASDAQ:ATAI - Benzinga

May 01, 2026
pulisher
May 01, 2026

Does AtaiBeckley’s (ATAI) EMP-01 Data Hint At A Scalable MDMA Therapy Platform? - Yahoo Finance

May 01, 2026
pulisher
May 01, 2026

Ataibeckley: Anxiety drug cuts social phobia symptoms by 38% - MSN

May 01, 2026
pulisher
May 01, 2026

ATAI Stock Price, Quote & Chart | ATAIBECKLEY INC (NASDAQ:ATAI) - ChartMill

May 01, 2026
pulisher
Apr 30, 2026

These stocks are today’s movers: Fermi, AST SpaceMobile, Intel, Marvell, USA Rare Earth, Ataibeckley, and more - MSN

Apr 30, 2026
pulisher
Apr 29, 2026

Why Ataibeckley stock surged today - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

Atai Beckley N.V. (ATAI) Receives a Buy from H.C. Wainwright - The Globe and Mail

Apr 29, 2026
pulisher
Apr 29, 2026

AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg - MSN

Apr 29, 2026
pulisher
Apr 28, 2026

Shroom stocks rise as Trump is said to sign executive order on psychedelic drug - MSN

Apr 28, 2026
pulisher
Apr 27, 2026

Psychedelic stocks soar as Trump signs order to ease access - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Small cap wrap: VivoPower, First Phosphate, ataiBeckley, Trillion Energy... - Proactive financial news

Apr 27, 2026
pulisher
Apr 27, 2026

AtaiBeckley wins OVID Health Silver Award for patient partnership in psychedelic trials - Proactive Investors

Apr 27, 2026
pulisher
Apr 27, 2026

Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research - Investing News Network

Apr 27, 2026
pulisher
Apr 27, 2026

AtaiBeckley and PsyPAN win silver for trial participant input - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

AtaiBeckley bets on next-gen psychedelic medicines to transform mental health - Proactive financial news

Apr 27, 2026
pulisher
Apr 26, 2026

Enveric Biosciences surges over 90%, other psychedelic stocks soar in Monday pre-market: What's going on? - MSN

Apr 26, 2026
pulisher
Apr 26, 2026

AtaiBeckley Inc.Common Stock (NQ: ATAI - The Chronicle-Journal

Apr 26, 2026
pulisher
Apr 25, 2026

AtaiBeckley’s EMP-01 Data Strengthen Case For Psychedelic Anxiety Pipeline - Sahm

Apr 25, 2026
pulisher
Apr 24, 2026

ATAI Stock Soars On Track For Best Day On Trump Psychedelics Push And Wall Street Cheers - Stocktwits

Apr 24, 2026

Ataibeckley Inc Azioni (ATAI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):